South African watchdog probes Novo Nordisk and Sanofi over insulin
South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...
Scoop10d
New Insulin Medicine Proposed For People With Diabetes
The proposal also advises that the supply of a different insulin medicine, NovoMix 30, is due to end in 2026. Both medicines are supplied by the same company, Novo Nordisk. Heyes says Pharmac ...
pharmaphorum3y
China's insulin plans will hit 2022 revenues, says Novo Nordisk
That suggests its top-selling insulin products like rapid-acting NovoRapid (insulin aspart), premix NovoMix (insulin aspart/insulin aspart protamine) and long-acting Tresiba (insulin degludec ...
South African Competition Commission probes Novo Nordisk and Sanofi over insulin pen market
South Africa's competition watchdog launches a crucial investigation into pharmaceutical giants Novo Nordisk and Sanofi over ...
Medscape2y
IMPROVE™ Observational Study of Biphasic Insulin Aspart 30/70 in Patients with Type 2 Diabetes Mellitus
They were eligible if their physician believed that they required insulin therapy ... Denmark] and NovoMix 30 FlexPen® 100 IU/ml suspension for injection in a prefilled pen [Novo Nordisk ...